7 Aug 2012
Clariant presents its new promise to pharma industry at CPhI 2012
CPhI 2012 Booth Booth: 5H23
October 9 – 11, 2012
Madrid, Spain
Muttenz, August 7, 2012 - Clariant's promise to create added value by appreciating the needs of its pharmaceutical sector customers will take center stage at the CPhI 2012, Booth #5H23.
Presented for the first time under the company’s new branding, the specialty chemicals expert’s trusted high purity, high quality tailored processing solutions can help meet the efficiency and performance requirements of specific pharmaceutical formulations.Clariant is a firm believer in working closely with customers in order to maximize the benefits of its extensive portfolio of building blocks, enhancers, and ingredients for the processing of sensitive applications.
A highlight for CPhI 2012 visitors will be Clariant’s broad portfolio of Pharmaceutical PEGs/ Macrogols, a leading product range under the trade name Polyglykol, used as API in laxatives and as excipients for tablets, suppository masses, organ preservation, protein purification and drug delivery systems. Clariant offers a complete range of different molecular weight, high purity PEGs supported by CEP certification and DMF.
“Appreciation is the key to delivering the innovative and competitive processing solutions required by the pharmaceutical sector. This philosophy of listening to our customers is at the heart of Clariant and we are excited to have the opportunity to present this to the pharmaceutical community within the fresh look and feel of our new company branding at the forthcoming CPhI,” comments Boris Segalowitch, Business Line Head Personal Care EMEA, Clariant.
Visit Clariant at Booth #5H23 CPhI 2012 October 9 – 11, 2012, Madrid, Spain.
Reader enquiries
Clariant International Ltd
Rothausstrasse 61
4132 Muttenz 1
Switzerland
Notes for editors
Clariant is an internationally active specialty chemical company, based in Muttenz near Basel. The group owns over 100 companies worldwide and employed 22 149 employees on December 31, 2011. In the financial year 2011, Clariant produced a turnover of CHF 7.4 billion. Clariant is divided into eleven business units: Additives; Catalysis & Energy; Emulsions, Detergents & Intermediates; Functional Materials; Industrial & Consumer Specialties; Leather Services; Masterbatches; Oil & Mining Services; Paper Specialties; Pigments; Textile Chemicals. Clariant focuses on creating value by investing in future profitable and sustainable growth, which is based on four strategic pillars: Improving profitability, innovation as well as research and development, dynamic growth in emerging markets, and optimizing the portfolio through complementary acquisitions or divestments.
Related images
Clariant presents its new promise to pharma industry at CPhI 2012.
(Photo: Clariant)
Editorial enquiries
Kai Rolker
Clariant International Ltd
Josina van der Velden
EMG